Status:
COMPLETED
Development and Validation of EHP-30 (Hong Kong Chinese Version) for Patients With Endometriosis and Adenomyosis
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Endometriosis
Adenomyosis
Eligibility:
FEMALE
18-55 years
Brief Summary
Endometriosis and adenomyosis can impact on the quality of life including the physical, psychological and social aspects. It is important to include quality of life measurements in evaluating the dise...
Detailed Description
Endometriosis is a chronic condition caused by the presence of ectopic endometrial tissue outside the uterus, affecting the fallopian tubes, ovaries, pelvic peritoneum or even the urinary and gastroin...
Eligibility Criteria
Inclusion
- Premenopausal
- Hong Kong Chinese women
- diagnosed with endometriosis or adenomyosis.
Exclusion
- uterine fibroid more than 5 cm
- other premalignant or malignant conditions
Key Trial Info
Start Date :
August 6 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2023
Estimated Enrollment :
448 Patients enrolled
Trial Details
Trial ID
NCT03302468
Start Date
August 6 2015
End Date
July 31 2023
Last Update
August 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Chinese University of Hong Kong
Hong Kong, Hong Kong